HOYA Corporation (HOCPF)
USD 138.44
(0.0%)
USD 138.44
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 213.23 Billion JPY | -2.51% |
| 2023 | 218.73 Billion JPY | 2.47% |
| 2022 | 213.44 Billion JPY | 26.01% |
| 2021 | 169.39 Billion JPY | 14.18% |
| 2020 | 148.35 Billion JPY | 1.51% |
| 2019 | 146.14 Billion JPY | 11.72% |
| 2018 | 130.81 Billion JPY | 16.53% |
| 2017 | 112.25 Billion JPY | -7.27% |
| 2016 | 121.05 Billion JPY | 1.1% |
| 2015 | 119.74 Billion JPY | 30.77% |
| 2014 | 91.56 Billion JPY | -1.09% |
| 2013 | 92.57 Billion JPY | 52.83% |
| 2012 | 60.57 Billion JPY | -11.3% |
| 2011 | 68.28 Billion JPY | 16.72% |
| 2010 | 58.5 Billion JPY | -16.44% |
| 2009 | 70.01 Billion JPY | -30.09% |
| 2008 | 100.14 Billion JPY | -0.85% |
| 2007 | 101 Billion JPY | -3.27% |
| 2006 | 104.41 Billion JPY | 22.33% |
| 2005 | 85.36 Billion JPY | 41.83% |
| 2004 | 60.18 Billion JPY | 98.36% |
| 2003 | 30.34 Billion JPY | -23.65% |
| 2002 | 39.74 Billion JPY | 20.33% |
| 2001 | 33.02 Billion JPY | -3.64% |
| 2000 | 34.27 Billion JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 59.61 Billion JPY | 8.27% |
| 2024 FY | 296.64 Billion JPY | 35.62% |
| 2024 Q4 | 52.3 Billion JPY | -7.54% |
| 2024 Q3 | 56.56 Billion JPY | 6.25% |
| 2024 Q2 | 53.24 Billion JPY | -10.69% |
| 2023 FY | 218.73 Billion JPY | 2.47% |
| 2023 Q1 | 61.96 Billion JPY | 12.42% |
| 2023 Q2 | 62.24 Billion JPY | 0.44% |
| 2023 Q4 | 55.06 Billion JPY | 39.57% |
| 2023 Q3 | 39.45 Billion JPY | -36.62% |
| 2022 Q1 | 51.6 Billion JPY | 9.96% |
| 2022 FY | 213.44 Billion JPY | 26.01% |
| 2022 Q4 | 55.12 Billion JPY | 5.09% |
| 2022 Q3 | 52.45 Billion JPY | -3.34% |
| 2022 Q2 | 54.26 Billion JPY | 5.15% |
| 2021 Q1 | 32.19 Billion JPY | 14.21% |
| 2021 Q4 | 46.93 Billion JPY | 1.13% |
| 2021 Q2 | 43.85 Billion JPY | 36.2% |
| 2021 Q3 | 46.4 Billion JPY | 5.82% |
| 2021 FY | 169.39 Billion JPY | 14.18% |
| 2020 Q2 | 44.42 Billion JPY | 19.38% |
| 2020 Q3 | 38.53 Billion JPY | -13.24% |
| 2020 FY | 148.35 Billion JPY | 1.51% |
| 2020 Q1 | 37.2 Billion JPY | 14.19% |
| 2020 Q4 | 28.19 Billion JPY | -26.84% |
| 2019 Q3 | 39.76 Billion JPY | 3.31% |
| 2019 Q4 | 32.58 Billion JPY | -18.07% |
| 2019 Q2 | 38.49 Billion JPY | 9.04% |
| 2019 Q1 | 35.3 Billion JPY | 10.9% |
| 2019 FY | 146.14 Billion JPY | 11.72% |
| 2018 Q1 | 30.8 Billion JPY | 23.25% |
| 2018 FY | 130.81 Billion JPY | 16.53% |
| 2018 Q4 | 31.83 Billion JPY | -9.05% |
| 2018 Q3 | 35 Billion JPY | 5.49% |
| 2018 Q2 | 33.17 Billion JPY | 7.7% |
| 2017 Q1 | 22.61 Billion JPY | -4.77% |
| 2017 Q4 | 24.99 Billion JPY | -23.65% |
| 2017 Q3 | 32.73 Billion JPY | 2.61% |
| 2017 Q2 | 31.9 Billion JPY | 41.08% |
| 2017 FY | 112.25 Billion JPY | -7.27% |
| 2016 FY | 121.05 Billion JPY | 1.1% |
| 2016 Q2 | 34.26 Billion JPY | 8.47% |
| 2016 Q1 | 31.59 Billion JPY | 23.28% |
| 2016 Q4 | 23.75 Billion JPY | -24.48% |
| 2016 Q3 | 31.44 Billion JPY | -8.23% |
| 2015 FY | 119.74 Billion JPY | 30.77% |
| 2015 Q4 | 25.62 Billion JPY | -29.7% |
| 2015 Q3 | 36.45 Billion JPY | 5.3% |
| 2015 Q2 | 34.61 Billion JPY | 52.13% |
| 2015 Q1 | 22.75 Billion JPY | -0.78% |
| 2014 Q1 | 21.12 Billion JPY | -32.13% |
| 2014 FY | 91.56 Billion JPY | -1.09% |
| 2014 Q2 | 17.66 Billion JPY | -16.38% |
| 2014 Q3 | 29.84 Billion JPY | 69.02% |
| 2014 Q4 | 22.93 Billion JPY | -23.16% |
| 2013 Q4 | 31.11 Billion JPY | 73.41% |
| 2013 Q3 | 17.94 Billion JPY | -57.86% |
| 2013 Q1 | 26.81 Billion JPY | 46.28% |
| 2013 FY | 92.57 Billion JPY | 52.83% |
| 2013 Q2 | 42.58 Billion JPY | 58.81% |
| 2012 Q1 | 42.8 Billion JPY | 180.68% |
| 2012 Q2 | 41.81 Billion JPY | -2.32% |
| 2012 Q3 | 7.12 Billion JPY | -82.96% |
| 2012 FY | 60.57 Billion JPY | -11.3% |
| 2012 Q4 | 18.32 Billion JPY | 157.32% |
| 2011 Q4 | 15.25 Billion JPY | -17.03% |
| 2011 Q1 | 17.64 Billion JPY | 0.39% |
| 2011 Q2 | 16.52 Billion JPY | -6.37% |
| 2011 Q3 | 18.38 Billion JPY | 11.24% |
| 2011 FY | 68.28 Billion JPY | 16.72% |
| 2010 Q3 | 18.88 Billion JPY | 26.18% |
| 2010 Q4 | 17.57 Billion JPY | -6.92% |
| 2010 Q2 | 14.96 Billion JPY | 110.71% |
| 2010 Q1 | 7.1 Billion JPY | 146.89% |
| 2010 FY | 58.5 Billion JPY | -16.44% |
| 2009 Q1 | 22.51 Billion JPY | 20.79% |
| 2009 Q3 | 18.4 Billion JPY | -29.79% |
| 2009 Q4 | 2.87 Billion JPY | -84.36% |
| 2009 FY | 70.01 Billion JPY | -30.09% |
| 2009 Q2 | 26.2 Billion JPY | 16.4% |
| 2008 FY | 100.14 Billion JPY | -0.85% |
| 2008 Q4 | 18.64 Billion JPY | -35.34% |
| 2008 Q3 | 28.82 Billion JPY | -0.1% |
| 2008 Q2 | 28.85 Billion JPY | 21.09% |
| 2008 Q1 | 23.82 Billion JPY | 0.0% |
| 2007 FY | 101 Billion JPY | -3.27% |
| 2006 FY | 104.41 Billion JPY | 22.33% |
| 2005 FY | 85.36 Billion JPY | 41.83% |
| 2004 FY | 60.18 Billion JPY | 98.36% |
| 2003 FY | 30.34 Billion JPY | -23.65% |
| 2002 FY | 39.74 Billion JPY | 20.33% |
| 2001 FY | 33.02 Billion JPY | -3.64% |
| 2000 FY | 34.27 Billion JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.16 Million USD | -18315338.663% |
| Ansell Limited | 129.3 Million USD | -164812.606% |
| Ansell Limited | 129.3 Million USD | -164812.606% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 31.13 Million USD | -684692.533% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.59 Million USD | 13363004.454% |
| Psykey, Inc. | -797.5 Thousand USD | 26737520.753% |
| ConvaTec Group Plc | 262.7 Million USD | -81069.395% |
| ConvaTec Group Plc | 262.7 Million USD | -81069.395% |
| Encision Inc. | -640.78 Thousand USD | 33276887.93% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 150364672.315% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 193970808.633% |
| Innovative MedTech Inc. | -4.27 Million USD | 4989061.357% |
| LifePoint, Inc. | -7.49 Million USD | 2845003.451% |
| Medite Cancer Diagnostics, Inc. | -6.48 Million USD | 3290717.284% |
| Paradigm Medical Industries, Inc. | 330 Thousand USD | -64615657.576% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -122.89 Thousand USD | 173514625.185% |
| Reflect Scientific, Inc. | -467.27 Thousand USD | 45632892.47% |
| SmileDirectClub, Inc. | -241.15 Million USD | 88520.773% |
| Sector 10, Inc. | -39.84 Thousand USD | 535167251.892% |
| Shandong Weigao Group Medical Polymer Company Limited | 319.6 Million USD | -66616.981% |
| SheerVision, Inc. | 155.72 Thousand USD | -136927580.67% |
| United Health Products, Inc. | -2.42 Million USD | 8787595.276% |
| Vasamed, Inc. | 4.74 Million USD | -4496281.715% |
| Wearable Health Solutions, Inc. | -2.29 Million USD | 9294733.591% |
| Yubo International Biotech Limited | -1.2 Million USD | 17692427.478% |